{
  "@context": {
    "bsc": "http://bioschemas.org/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@id": "https://bio.tools/pandrugs",
  "@type": "sc:SoftwareApplication",
  "edam:has_input": {
    "@id": "edam:data_2299"
  },
  "edam:has_output": {
    "@id": "edam:data_1621"
  },
  "sc:additionalType": [
    "Web API",
    "Database portal"
  ],
  "sc:applicationSubCategory": [
    {
      "@id": "edam:topic_0622"
    },
    {
      "@id": "edam:topic_2640"
    },
    {
      "@id": "edam:topic_2533"
    }
  ],
  "sc:citation": [
    "pubmed:29848362",
    "pmcid:PMC5977747"
  ],
  "sc:description": "PanDrugs is a method to prioritize anticancer drug treatments according to individual genomic data. PanDrugs current version integrates data from 24 primary sources and supports 56297 drug-target associations obtained from 4804 genes and 9092 unique compounds.",
  "sc:featureList": {
    "@id": "edam:operation_3226"
  },
  "sc:license": "GPL-3.0",
  "sc:name": "PanDrugs",
  "sc:url": "https://www.pandrugs.org/",
  "sc:version": "2018.06.18"
}